Omega Diagnostics Group PLC Director/PDMR Shareholding (8370Y)
10 May 2023 - 12:42AM
UK Regulatory
TIDMODX
RNS Number : 8370Y
Omega Diagnostics Group PLC
09 May 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director/PDMR Shareholding
Omega (AIM: ODX), the specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition, announces that it has received notification
that Jag Grewal, Chief Executive Officer, and Chris Lea, Chief
Financial Officer, each purchased 69,498 ordinary shares of 4 pence
each in the Company ("Ordinary Shares") on 5 May 2023 through the
Company's all-employee Share Incentive Plan, at a price of 2.59
pence each. At the same time, these individuals were also awarded
(for no consideration) their corresponding Matching Shares under
the plan.
A summary of each Directors resultant holdings is below:
Director Board Number of Partnership Number of Total beneficial holding
Position Shares acquired Matching Shares of Ordinary Shares following
under the SIP acquired under these acquisitions
on 5 May 2023 the SIP on
5 May 2023
Number of Approximate
Ordinary % of Company's
Shares issued share
capital
------------
Jag Grewal CEO 69,498 69,498 2,164,830 0.91%
----------- ---------------------- ----------------- ------------ ------------------
Chris
Lea CFO 69,498 69,498 2,169,904 0.91%
----------- ---------------------- ----------------- ------------ ------------------
Contacts:
Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/Charlotte Sutcliffe (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company
focused on promoting a personalised and functional approach to
health and nutrition .
www.omegadx.com
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014. Upon the publication
of this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Jag Grewal
------------------------- -------------------------------------
Reason for the notification
2
----------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------- -------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------- -------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
------------------------- -------------------------------------
b) LEI 2138007U9P4BTZTYIR92
------------------------- -------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each
of the financial
instrument,
type of instrument
Identification ISIN: GB00B1VCP282
code
------------------------- -------------------------------------
b) Nature of Ordinary Shares purchased
the transaction
------------------------- -------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
2.59 pence 69,498
------------ ----------
------------------------- -------------------------------------
d) Aggregated See above
information
-Aggregated
volume
- Price
------------------------- -------------------------------------
e) Date of the 05.05.2023
transaction
------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction
------------------------- -------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Chris Lea
------------------------- -------------------------------------
Reason for the notification
2
----------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------- -------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------- -------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
------------------------- -------------------------------------
b) LEI 2138007U9P4BTZTYIR92
------------------------- -------------------------------------
Details of the transaction(s): section to be repeated for
4 (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
----------------------------------------------------------------
a) Description Ordinary Shares of 4 pence each
of the financial
instrument,
type of instrument
Identification ISIN: GB00B1VCP282
code
------------------------- -------------------------------------
b) Nature of Ordinary Shares purchased
the transaction
------------------------- -------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
2.59 pence 69,498
------------ ----------
------------------------- -------------------------------------
d) Aggregated See above
information
-Aggregated
volume
- Price
------------------------- -------------------------------------
e) Date of the 05.05.2023
transaction
------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction
------------------------- -------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBSGDUDXGDGXC
(END) Dow Jones Newswires
May 09, 2023 10:42 ET (14:42 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024
